Featured Top Story
The FDA says it will offer ultra-fast review to three psychedelic drugs being studied for hard-to-treat mental health conditions.
From
To
Featured Top Story
The experts cited flawed study data and potential safety risks of MDMA, including heart problems.
California lawmakers will consider next year whether to decriminalize psychedelic drugs.
A psychedelic advocacy group has brought MDMA - the illegal party drug also known as ecstasy - to the brink of medical legitimacy.